Cargando…
Endostatin gene variation and protein levels in breast cancer susceptibility and severity
BACKGROUND: Endostatin is a potent endogenous anti-angiogenic agent which inhibits tumour growth. A non-synonymous coding polymorphism in the Endostatin gene is thought to affect Endostatin activity. We aimed to determine the role of this Endostatin polymorphism in breast cancer pathogenesis and any...
Autores principales: | Balasubramanian, Sabapathy P, Cross, Simon S, Globe, Jenny, Cox, Angela, Brown, Nicola J, Reed, Malcolm W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924861/ https://www.ncbi.nlm.nih.gov/pubmed/17587451 http://dx.doi.org/10.1186/1471-2407-7-107 |
Ejemplares similares
-
A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
por: Searle, Claire J, et al.
Publicado: (2012) -
Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity
por: Azmy, Iman AF, et al.
Publicado: (2004) -
Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
por: Bachelot, T, et al.
Publicado: (2006) -
Endostatin in the pancreas
por: Wigmore, S J
Publicado: (2005) -
Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
por: Wang, Shan, et al.
Publicado: (2016)